
Amplity Studies At ISPOR 2025 Highlight Trends In GLP-1 Receptor Agonists & Biologic Treatments For UC & CD Patients
MONTREAL, QC, CANADA, May 15, 2025 /EINPresswire.com/ -- Amplity presented findings from 3 studies at the annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 conference in Montreal, QC, Canada. These real-world analyses …